HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.

Abstract
The effects of propranolol and atenolol were investigated on arterial hypertension, cardiomyocyte hypertrophy, and ventricular ischaemic lesions induced by an 8-week treatment with the nitric oxide synthase inhibitor N(omega)-nitro-L-arginine methyl ester (L-NAME; 20 mg/rat per day) in Wistar rats. Propranolol and atenolol (30 mg/rat per day each) were given in the drinking water concomitantly to L-NAME. Treatment with L-NAME induced marked arterial hypertension and cardiomyocyte hypertrophy, both of which were significantly reduced by propranolol and atenolol. A marked repairing fibrosis was also observed in L-NAME-treated rats and this was significantly attenuated in animals receiving the beta-blockers. In L-NAME group, 33% mortality was observed, whereas all the animals from the other groups survived. Our study demonstrates that propranolol and atenolol reduce arterial hypertension, cardiomyocyte hypertrophy and myocardial fibrosis induced by L-NAME, suggesting that beta-blockers are of beneficial value in treatment of vascular and cardiac alterations caused by chronic nitric oxide deficiency.
AuthorsSandra R M C Pacca, Ana Paula de Azevedo, Claudia F De Oliveira, Iara M S De Luca, Gilberto De Nucci, Edson Antunes
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 39 Issue 2 Pg. 201-7 (Feb 2002) ISSN: 0160-2446 [Print] United States
PMID11791005 (Publication Type: Journal Article)
Chemical References
  • Adrenergic beta-1 Receptor Antagonists
  • Adrenergic beta-Antagonists
  • Enzyme Inhibitors
  • Nitric Oxide
  • Atenolol
  • Propranolol
  • Nitric Oxide Synthase
  • NG-Nitroarginine Methyl Ester
Topics
  • Adrenergic beta-1 Receptor Antagonists
  • Adrenergic beta-Antagonists (pharmacology, therapeutic use)
  • Animals
  • Atenolol (pharmacology, therapeutic use)
  • Blood Pressure (drug effects)
  • Body Weight (drug effects)
  • Enzyme Inhibitors
  • Fibrosis
  • Heart (anatomy & histology, drug effects)
  • Hypertension (chemically induced, drug therapy)
  • Hypertrophy, Left Ventricular (chemically induced, drug therapy, pathology)
  • Male
  • Myocardium (pathology)
  • NG-Nitroarginine Methyl Ester
  • Nitric Oxide (deficiency)
  • Nitric Oxide Synthase (antagonists & inhibitors)
  • Organ Size (drug effects)
  • Propranolol (pharmacology, therapeutic use)
  • Rats
  • Rats, Wistar
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: